PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Experimental Emergency Medicine10.15441/ceem.22.276202293246-252The DEXA-SEPSIS study protocol: a phase II randomized double-blinded controlled trial of the effect of early dexamethasone in high-risk sepsis patientsKihwan Choi, Jong Eun Park, Anhye Kim, Sojung Hwang, Jinkun Bae, Tae Gun Shin, Kyuseok Kimhttp://ceemjournal.org/upload/pdf/ceem-22-276.pdf, http://ceemjournal.org/journal/view.php?doi=10.15441/ceem.22.276, http://ceemjournal.org/upload/pdf/ceem-22-276.pdf
10.21203/rs.3.rs-18359/v12020Prophylactic prednisolone for the prevention of early and intermediate adverse effects of radioactive iodine therapy in patients with thyroid cancer: study protocol for a single centre, phase II/III, randomized, double blinded, placebo controlled clinical trialUmesh Jayarajah, Mahilal Wijekoon, Sanjeewa Seneviratnehttps://www.researchsquare.com/article/rs-18359/v1, https://www.researchsquare.com/article/rs-18359/v1.html
10.21203/rs.2.16361/v22020The effect of Xuanbai Chengqi decoction on patients with pneumonia-derived sepsis: study protocol for a randomized controlled trialZhang Jun, Yi Yu, Bojun Zheng, Huang Jinghttps://www.researchsquare.com/article/rs-7004/v2, https://www.researchsquare.com/article/rs-7004/v2.html
10.21203/rs.2.16361/v12019The effect of Xuanbai Chengqi decoction on patients with pneumonia-derived sepsis: study protocol for a randomized controlled trialZhang Jun, Yi Yu, Bojun Zheng, Huang Jinghttps://www.researchsquare.com/article/rs-7004/v1, https://www.researchsquare.com/article/rs-7004/v1.html
Trials10.1186/s13063-020-04744-x2020211Prophylactic prednisolone for the prevention of early and intermediate adverse effects of radioactive iodine therapy in patients with thyroid cancer: study protocol for a single-centre, phase II/III, randomized, double-blinded, placebo-controlled clinical trialUmesh Jayarajah, Mahilal Wijekoon, Sanjeewa A. Seneviratnehttps://link.springer.com/content/pdf/10.1186/s13063-020-04744-x.pdf, https://link.springer.com/article/10.1186/s13063-020-04744-x/fulltext.html, https://link.springer.com/content/pdf/10.1186/s13063-020-04744-x.pdf
PLOS ONE10.1371/journal.pone.025969920211611e0259699Early administration of Vitamin C in patients with sepsis or septic shock in emergency departments: A multicenter, double blinded, randomized controlled trial: The C-EASIE trial protocolStefanie Vandervelden, Lina Wauters, Jan Breuls, Steffen Fieuws, Philippe Vanhove, Ives Hubloue, Magali Bartiaux, Jacques Creteur, François Stifkens, Koen Monsieurs, Didier Desruelleshttps://dx.plos.org/10.1371/journal.pone.0259699
10.21203/rs.3.rs-19709/v12020Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitisJonathan Wickel, Ha-Yeun Chung, Stephanie Platzer, Thomas Lehmann, Harald Prüss, Frank Leypoldt, Albrecht Günther, André Scherag, Christian Geishttps://www.researchsquare.com/article/rs-19709/v1, https://www.researchsquare.com/article/rs-19709/v1.html
10.21203/rs.3.rs-2624306/v12023MEsh FIxation in Laparoendsocopic Repair of Large M3 Inguinal Hernias - Multicenter, Double-blinded, Randomized Controlled Trial – study protocol for a MEFI TrialMateusz Zamkowski, Maciej Śmietańskihttps://www.researchsquare.com/article/rs-2624306/v1, https://www.researchsquare.com/article/rs-2624306/v1.html
Trials10.1186/1745-6215-11-502010111The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injurySean M Bagshaw, R T Noel Gibney, Finlay A McAlister, Rinaldo Bellomohttp://link.springer.com/article/10.1186/1745-6215-11-50/fulltext.html, http://link.springer.com/content/pdf/10.1186/1745-6215-11-50.pdf, http://link.springer.com/content/pdf/10.1186/1745-6215-11-50, http://link.springer.com/content/pdf/10.1186/1745-6215-11-50.pdf
Trials10.1186/s13063-018-2836-82018191Pharm-MD; an open-label, randomized controlled, phase II study to evaluate the efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients – study protocol for a randomized controlled trialAlexandra Halalau, Daniel Shelden, Scott Keeney, Jaspreet Heharhttp://link.springer.com/content/pdf/10.1186/s13063-018-2836-8.pdf, http://link.springer.com/article/10.1186/s13063-018-2836-8/fulltext.html, http://link.springer.com/content/pdf/10.1186/s13063-018-2836-8.pdf